Literature DB >> 17361218

Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression.

A Sengupta1, D Banerjee, S Chandra, S K Banerji, R Ghosh, R Roy, S Banerjee.   

Abstract

Deciphering the BCR-ABL-independent signaling exploited in chronic myeloid leukemia (CML) progression is an important aspect in cancer stem-cell biology. CML stem-cell compartment is dynamic as it progresses to terminal blast crisis where myeloid and lymphoid blasts fail to differentiate. We demonstrate cross-regulation of signaling network involving Sonic hedgehog (Shh), Wnt, Notch and Hox for the inexorable blastic transformation of CD34(+) CML cells. Significant upregulation in Patched1, Frizzled2, Lef1, CyclinD1, p21 (P < or =0.0002) and downregulation of HoxA10 and HoxB4 (P< or =0.0001) transcripts in CD34(+) cells distinguish blast crisis from chronic CML. We report Shh-dependent Stat3 activation orchestrates these mutually interconnected signaling pathways. Stimulation of CD34(+) CML cells with either soluble Shh or Wnt3a did not activate Akt or p44/42-mitogen activated protein kinase (MAPK) pathways. Interestingly, unlike dominant negative Stat3beta, introduction of constitutive active Stat3 in CD34(+) CML cells induces cross-regulation in gene expression. Additionally, Shh and Wnt3a-dependent regulation of cyclin-dependent kinase inhibitors (CDKI) in CML suggests their role in the network. Taken together, our findings propose that deregulation in the form of hyperactive Shh and Wnt with repressed Notch and Hox pathways involving Stat3, Gli3, beta-catenin, CyclinD1, Hes1, HoxA10 and p21 might act synergistically to form an important hub in CML progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17361218     DOI: 10.1038/sj.leu.2404657

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  67 in total

Review 1.  Cancer stem cells: a stride towards cancer cure?

Authors:  Amitava Sengupta; Jose A Cancelas
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

Review 2.  Molecular pathways to CML stem cells.

Authors:  Kristen N Rice; Catriona H M Jamieson
Journal:  Int J Hematol       Date:  2010-06-10       Impact factor: 2.490

Review 3.  Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Aspects Med       Date:  2013-08-29

4.  Two waves of distinct hematopoietic progenitor cells colonize the fetal thymus.

Authors:  Cyrille Ramond; Claire Berthault; Odile Burlen-Defranoux; Ana Pereira de Sousa; Delphine Guy-Grand; Paulo Vieira; Pablo Pereira; Ana Cumano
Journal:  Nat Immunol       Date:  2013-12-08       Impact factor: 25.606

5.  Epigenetic regulation of WNT signaling in chronic lymphocytic leukemia.

Authors:  Lynda B Bennett; Kristen H Taylor; Gerald L Arthur; Farahnaz B Rahmatpanah; Sam I Hooshmand; Charles W Caldwell
Journal:  Epigenomics       Date:  2010-02-01       Impact factor: 4.778

6.  HOXA4 provides stronger engraftment potential to short-term repopulating cells than HOXB4.

Authors:  Marilaine Fournier; Charles-Étienne Lebert-Ghali; Janetta J Bijl
Journal:  Stem Cells Dev       Date:  2015-08-12       Impact factor: 3.272

7.  Hedgehog signaling pathway: the must, the maybe and the unknown.

Authors:  Paul Zarogoulidis; Katerina Zarampouka; Haidong Huang; Kaid Darwiche; Yong Huang; Antonis Sakkas; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

Review 8.  Stem cells and cancer: an overview.

Authors:  Kevin M Sales; Marc C Winslet; Alexander M Seifalian
Journal:  Stem Cell Rev       Date:  2007-12       Impact factor: 5.739

Review 9.  Notch signaling in glioblastoma: a developmental drug target?

Authors:  Maria Maddalena Lino; Adrian Merlo; Jean-Louis Boulay
Journal:  BMC Med       Date:  2010-11-15       Impact factor: 8.775

10.  Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines.

Authors:  Shinji Mizuarai; Aki Kawagishi; Hidehito Kotani
Journal:  Mol Cancer       Date:  2009-07-06       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.